{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:48:36Z","timestamp":1790747316995,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":74,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010067","name":"Government of Aragon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Business","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100355","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T05:56:26Z","timestamp":1616219786000},"page":"100355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["In vivo potential of recombinant granulysin against human melanoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Sameer","family":"Al-Wasaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Guerrero-Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ib\u00e1\u00f1ez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Lostao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Anel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2021.100355_bib0001","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.4049\/jimmunol.158.6.2680","article-title":"Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins","volume":"158","author":"Pe\u00f1a","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0002","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1200570","article-title":"15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity","volume":"188","author":"Clayberger","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2018.12.031","article-title":"Granulysin species segregate to different lysosome-related effector vesicles (LREV) and get mobilized by either classical or non-classical degranulation","volume":"107","author":"Lettau","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ctarc.2021.100355_bib0005","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.165.12.7102","article-title":"Granulysin, a T cell product, kills bacteria by altering membrane permeability","volume":"165","author":"Ernst","year":"2000","journal-title":"J Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0006","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.4049\/jimmunol.169.10.5787","article-title":"CD8 T cell-mediated killing of Cryptcoccus neoformans requires granulysin and is dependent on CD4 T cells and IL-15","volume":"169","author":"Ma","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/088282401750234501","article-title":"Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells","volume":"14","author":"Hata","year":"2001","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/84620","article-title":"T-cell relese of granulysin contributes to host defense in leprosy","volume":"7","author":"Ochoa","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2021.100355_bib0009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nm.4023","article-title":"Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites","volume":"22","author":"Dotiwala","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2021.100355_bib0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.03.062","article-title":"Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes","volume":"157","author":"Walch","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2021.100355_bib0011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bcp.2013.11.004","article-title":"Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors","volume":"87","author":"Aporta","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0012","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.4049\/jimmunol.171.5.2556","article-title":"Intracellular mediators of granulysin-induced cell death","volume":"171","author":"Okada","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0013","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.0802502","article-title":"Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to necroptosis","volume":"182","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0014","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.167.3.1222","article-title":"A role of the mitochondrial apoptosis-inducing factor (AIF) in granulysin-induced apoptosis","volume":"167","author":"Pardo","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0015","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1003409","article-title":"Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells","volume":"186","author":"Saini","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4049\/jimmunol.178.1.77","article-title":"Granulysin-mediated tumor rejection in transgenic mice","volume":"178","author":"Huang","year":"2007","journal-title":"J Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1036213","article-title":"In vivo potential of recombinant granulysin against human tumors","volume":"4","author":"Al-Wasaby","year":"2015","journal-title":"OncoImmunol"},{"key":"10.1016\/j.ctarc.2021.100355_bib0018","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin Oncol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","article-title":"Immune modulation in cancer with antibodies","volume":"65","author":"Page","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ctarc.2021.100355_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin Oncol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10969-005-2827-3","article-title":"On-column protein refolding for crystallization","volume":"6","author":"Oganesyan","year":"2005","journal-title":"J. Struct Func. Genomics"},{"key":"10.1016\/j.ctarc.2021.100355_bib0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccr.2014.04.030","article-title":"RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway","volume":"26","author":"Alonso-Curbelo","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2021.100355_bib0023","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s002620100228","article-title":"Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer","volume":"50","author":"Kishi","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ctarc.2021.100355_bib0024","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1532\/IJH97.05091","article-title":"Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: case report","volume":"82","author":"Nagasawa","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ctarc.2021.100355_bib0025","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.ctarc.2021.100355_bib0026","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1440-1746.2006.04796.x","article-title":"Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma","volume":"22","author":"Saigusa","year":"2007","journal-title":"J Gastroenterol. Hepatol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0027","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.167.1.350","article-title":"A distinct pathway of cell-mediated apoptosis initiated by granulysin","volume":"167","author":"Kaspar","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100355_bib0028","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J Exp. Med."},{"key":"10.1016\/j.ctarc.2021.100355_bib0029","doi-asserted-by":"crossref","first-page":"e27878","DOI":"10.4161\/onci.27878","article-title":"Trial watch: chemotherapy with immunogenic cell death inducers","volume":"3","author":"Vacchelli","year":"2014","journal-title":"OncoImmunol"},{"key":"10.1016\/j.ctarc.2021.100355_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ctarc.2021.100355_bib0031","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMe1205943","article-title":"Tumor immunotherapy directed at PD-1","volume":"366","author":"Ribas","year":"2012","journal-title":"New Eng. J. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:21:39Z","timestamp":1762842099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":31,"alternative-id":["S2468294221000538"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100355","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo potential of recombinant granulysin against human melanoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100355"}}